Streetbeat News

Partnerships

CCG

Cheche Group (CCG) has announced a partnership with Volkswagen (Anhui) Digital Sales and Services to bolster its New Energy Vehicle (NEV) insurance business. This collaboration aims to leverage Volkswagen Anhui's digital capabilities to enhance insurance offerings for NEV customers, potentially increasing market share and customer satisfaction for both entities.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 1:02 pm

APDN

The Institute of Hematology and Blood Transfusion will present its use of Applied DNA's Linea DNATM technology for the non-viral manufacture of CAR T-cell therapy aimed at treating refractory AML. This showcases a significant application of Applied DNA's technology in advancing cancer treatment.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 1:01 pm

AAPL

MSFT

Apple Inc. is nearing a partnership with OpenAI to integrate ChatGPT into iOS 18 and the iPhone 16, potentially introducing a new revenue stream through a subscription service for advanced AI features. This collaboration, expected to be announced at WWDC on June 10, could significantly enhance Siri's capabilities and attract developers to the Apple ecosystem, also benefiting Microsoft Corp.'s developer ecosystem.

Portfolio Pulse from Rounak Jain

May 13, 2024 | 12:55 pm

NFLX

SPY

Netflix Inc (NASDAQ:NFLX) receives an optimistic outlook from JPMorgan ahead of its Upfront presentation on May 16, with a focus on ad tier updates and potential NFL game hosting. Analyst Doug Anmuth maintains an Overweight rating with a $650 price target, citing revenue outlook comfort, subscriber reporting changes, and lower AI-driven capex intensity compared to competitors. Netflix's ad tier growth, driven by bundles, pricing, and marketing, is highlighted as a key revenue driver for the future. The company's stock has rebounded post-earnings, outperforming the S&P 500 as represented by the iShares S&P 500 ETF (NYSE:SPY).

Portfolio Pulse from Surbhi Jain

May 13, 2024 | 12:52 pm

BR

KD

Broadridge Financial Solutions, Inc. (BR) is set to acquire Kyndryl's Securities Industry Services (SIS) wealth and capital markets technology platform, aimed at enhancing services for Canadian financial firms. Kyndryl will partner with Broadridge Canada to provide managed services for SIS.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 12:50 pm

SHOT

Safety Shot has announced a collaboration with Gopuff, planning to launch a marketing campaign to support Gopuff's services. Safety Shot products will also be available in Gopuff subsidiaries, indicating a strategic partnership aimed at boosting the visibility and distribution of Safety Shot products through Gopuff's extensive delivery network.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 12:49 pm

AREC

American Resources Corporation (AREC) through its subsidiary ReElement Technologies, announced a strategic partnership with LVC Global Holdings to enhance metal refining and recycling in Africa. This collaboration aims to redefine refining and recycling practices for rare earth and critical minerals in Emerging & Frontier Markets, particularly in Sub-Saharan Africa, by leveraging innovative technology and market expertise.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 12:42 pm

OKLO

Oklo shares have seen increased trading activity and volatility following its business combination with AltC Acquisition Corp. and its recent debut on the NYSE. Additionally, Oklo announced a memorandum of understanding (MOU) with Atomic Alchemy to collaborate on isotope production.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 12:42 pm

ACIU

GME

TVGN

GameStop, AC Immune, and Tevogen Bio Holdings saw significant stock price movements due to various factors. GME rose amid retail investor interest sparked by Roaring Kitty. ACIU surged after Q1 financial results and a deal with Takeda for Alzheimer's treatment. TVGN climbed following a financing agreement for up to $50 million.

Portfolio Pulse from ryanfaloona@benzinga.com

May 13, 2024 | 12:42 pm

ABBV

AbbVie has entered into a collaboration and option-to-license agreement with Gilgamesh Pharmaceuticals to develop next-generation neuroplastogens for psychiatric disorders. This partnership combines AbbVie's expertise in psychiatry with Gilgamesh's innovative research platform.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 12:40 pm